Vicagrel

DB16349InvestigationalSmall molecule

Vicagrel is under investigation in clinical trial NCT03599284 (The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel).

Chemical structure of Vicagrel
Formula / weight
C18H18ClNO4S · 379.86 g/mol (avg)

Resolves to

Compound
UNII8A63K3TN0UCAS1314081-53-2ChEMBLCHEMBL2042273
Structure
InChIKeyGNHHCBSBCDGWND-KRWDZBQOSA-NSMILESCOC(=O)[C@@H](N1CCC2=C(C1)C=C(OC(C)=O)S2)C1=C(Cl)C=CC=C1
Targets
Q9H244P2RY12

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
17+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Vicagrel, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In